Fig. 1.
Coomassie blue stained gel showing SDS-PAGE analysis of the purified recombinant antigens incorporated into the multivalent vaccine. M1, Protein Ladder; Lane 1, Histamine binding protein (male variant); Lane 2, Histamine binding protein (female variant 1); Lane 3, Histamine binding protein (female variant 2); Lane 4, TRP64 (truncated); Lane 5, TRP64 full length; Lane 6, Subolesin; Lane M2, Protein Ladder; Lane 7, p67C